Moreover, sildenafil treatment reduced LV mass and mass/volume ratio in diabetic cardiomyopathy patients with concentric remodeling [39], emphasizing the important role of the PKG on the one hand, while simultaneously suggesting augmentation of PKG activity as a potential therapeutical target on the other hand. Here, PRKG1 is linked to diabetic cardiomyopathy.